Abstract:ABSTRACT Heteroresistance refers to phenotypic heterogeneity of microbial clonal populations under antibiotic stress, and it has been thought to be an allocation of a subset of “resistant” cells for surviving in higher concentrations of antibiotic. The assumption fits the so-called bet-hedging strategy, where a bacterial population “hedges” its “bet” on different phenotypes to be selected by unpredicted environment stresses. To test this hypothesis, we constructed a heteroresistance model by introducing a blaCTX-M-14 gene (coding for a cephalosporin hydrolase) into a sensitive Escherichia coli strain. We confirmed heteroresistance in this clone and that a subset of the cells expressed more hydrolase and formed more colonies in the presence of ceftriaxone (exhibited stronger “resistance”). However, subsequent single-cell-level investigation by using a microfluidic device showed that a subset of cells with a distinguishable phenotype of slowed growth and intensified hydrolase expression emerged, and they were not positively selected but increased their proportion in the population with ascending antibiotic concentrations. Therefore, heteroresistance—the gradually decreased colony-forming capability in the presence of antibiotic—was a result of a decreased growth rate rather than of selection for resistant cells. Using a mock strain without the resistance gene, we further demonstrated the existence of two nested growth-centric feedback loops that control the expression of the hydrolase and maximize population growth in various antibiotic concentrations. In conclusion, phenotypic heterogeneity is a population-based strategy beneficial for bacterial survival and propagation through task allocation and interphenotypic collaboration, and the growth rate provides a critical control for the expression of stress-related genes and an essential mechanism in responding to environmental stresses. IMPORTANCE Heteroresistance is essentially phenotypic heterogeneity, where a population-based strategy is thought to be at work, being assumed to be variable cell-to-cell resistance to be selected under antibiotic stress. Exact mechanisms of heteroresistance and its roles in adaptation to antibiotic stress have yet to be fully understood at the molecular and single-cell levels. In our study, we have not been able to detect any apparent subset of “resistant” cells selected by antibiotics; on the contrary, cell populations differentiate into phenotypic subsets with variable growth statuses and hydrolase expression. The growth rate appears to be sensitive to stress intensity and plays a key role in controlling hydrolase expression at both the bulk population and single-cell levels. We have shown here, for the first time, that phenotypic heterogeneity can be beneficial to a growing bacterial population through task allocation and interphenotypic collaboration other than partitioning cells into different categories of selective advantage.

Evaluating the predictive power of combined gene expression dynamics from single cells on antibiotic survival

Forecasting when cells die during antibiotic exposure using stochastic gene expression

Forecasting cell fate during antibiotic exposure using stochastic gene expression

Gene expression tradeoffs determine bacterial survival and adaptation to antibiotic stress

Studies Of The Drug Resistance Response Of Sensitive And Drug-Resistant Strains In A Microfluidic System

A quantitative approach to easily characterize and predict cell death and escape to β-lactam treatments

Dynamic gene expression and growth underlie cell-to-cell heterogeneity in Escherichia coli stress response

Trade-offs between drug toxicity and benefit in the multi-antibiotic resistance system underlie optimal growth of E. coli

Suppression of bacterial cell death underlies the antagonistic interaction between ciprofloxacin and tetracycline in

Quantifying Dynamic Phenotypic Heterogeneity in Resistant Escherichia Coli under Translation‐Inhibiting Antibiotics

Common regulatory mutation increases single-cell survival to antibiotic exposures in .

Dynamical model of antibiotic responses linking expression of resistance genes to metabolism explains emergence of heterogeneity during drug exposures

Measuring single-cell susceptibility to antibiotics within monoclonal bacterial populations

Heteroresistance at the Single-Cell Level: Adapting to Antibiotic Stress Through a Population-Based Strategy and Growth-Controlled Interphenotypic Coordination

Single-cell Microfluidics Enabled Dynamic Evaluation of Drug Combinations on Antibiotic Resistance Bacteria

Antibiotic resistant bacteria survive treatment by doubling while shrinking

Nonoptimal Gene Expression Creates Latent Potential for Antibiotic Resistance

Prediction of antibiotic resistance evolution by growth measurement of all proximal mutants of beta-lactamase

Integrating CRISPR-Enabled Trackable Genome Engineering and Transcriptomic Analysis of Global Regulators for Antibiotic Resistance Selection and Identification in Escherichia coli

Single Cell Growth Rate And Morphological Dynamics Revealing An "Opportunistic" Persistence

Pleiotropic cellular responses underlying antibiotic tolerance in